Peter Sims

Peter Sims

Titles

Assistant Professor, Department of Systems Biology

Affiliations

Department of Biochemistry and Molecular Biophysics
Department of Systems Biology
JP Sulzberger Columbia Genome Center
Center for Cancer Systems Therapeutics

Phone

(212) 305-2687

Peter Sims joined Columbia in 2012 as an assistant professor in the Department of Biochemistry and Molecular Biophysics. Researchers in his laboratory are working to improve single-cell approaches to systems biology. These approaches are crucial because individual cells respond in different ways to identical chemical and genetic perturbations, and because clinical samples are often limited to small numbers of cells. Translating new and existing techniques for genome-wide analysis to the single cell level will facilitate their application to biomedicine. The Sims Lab develops new tools for single-cell analysis, applying cutting-edge microscopy, next-generation sequencing, and microfabrication to enable unbiased, system-wide measurements of biological samples. He and his colleagues focus on single-cell transcriptomics and sequencing technology along with novel approaches to proteomics, where current tools lag far behind those available for nucleic acid analysis.

More News

News

Advancing the Use of Single-Cell Technology for Novel Brain Cancer Treatment
The Mark Foundation for Cancer Research has awarded Dr. Peter Sims an Emerging Leader Award and will support his work to advance a novel use of single-cell RNA sequencing to develop brain cancer treatments. Dr. Sims, an early contributor to the emerging field of single-cell RNA sequencing, is one of just eight recipients of the inaugural grant, given to promising early career scientists for projects aimed at unmet needs in cancer risk prediction, prevention and treatment.
Integrating Single-Cell Sequencing with Live Cell Imaging
Jointly awarded a $1.5 million NIH grant, the Sims Lab and Cell Microsystems are collaborating to build and test a novel single-cell analysis platform that enables live cell imaging on a large scale and at low cost.
PLATE-Seq to Advance Personalized Cancer Treatment
Drug screening and analysis is critical in advancing research of cancer therapeutics. To this end, a Systems Biology-led team has developed PLATE-Seq, a new technique for low-cost, bulk mRNA sequencing. Coupled with genome-wide regulatory network analysis, the new method advances the goal of providing personalized treatment to patients.
Systems Biology Faculty Nab Chan Zuckerberg Initiative Grants to Advance Human Cell Atlas
The Chan Zuckerberg Initiative, cofounded by Facebook CEO Mark Zuckerberg, is supporting single-cell genomics research by Peter Sims (pictured above) and Raul Rabadan to help advance the Human Cell Atlas project. Launched in 2016, the Human Cell Atlas is attempting to identify and define every cell type and create a collection of maps to describe the cellular basis of health and disease.
Erin Bush Receives CP&S Officer of Research Award
A staff associate in the Department of Systems Biology and Columbia Genome Center, Erin helped develop a low cost, high throughout RNA-sequencing technology that allows researchers to screen drugs for genetic effects.